Establishment Labs Holdings Inc. (ESTA) is a global medical technology company with a primary focus on improving patient safety and aesthetic outcomes. The company has significantly distinguished itself as a trailblazer in the field, specifically in the manufacturing of silicone-filled breast and body shaping implants.
Founded in 2004, the company is headquartered in San Jose, Costa Rica, but also operates from Costa Rica, Florida, Belgium, and the Netherlands. The activities of ESTA are internationally widespread, with more than 70 countries worldwide benefitting from the company's high-quality, innovative products.
ESTA is recognized for the invention and commercialization of Motiva Implants®, the flagship product of the company. These implants are renowned for their advanced, state-of-the-art Ergonomix® design. The Ergonomix® design excellently mimics the look, feel, and movement of natural breasts, and the implants are composed of a proprietary silicone gel which further enhances the natural aesthetic.
In its commitment to prioritizing patient safety, Establisment Labs developed the MotivaImagine® Platform, a unique combination of technologies and services that seek to reduce the common complications associated with implants surgeries. It integrates Q Inside Safety Technology™, a radiofrequency identification (RFID) microtransponder that gives surgeons and patients access to implant-specific data before and after surgery.
Another pivotal achievement is their Q portfolio, which includes products such as the Q Inside Safety Technology (QIST), MotivaEdge, and Q Traceability. The QIST technology enables implant security and traceability, providing vital information about the implant such as manufacturing data and life cycle when scanned with a Q reader.
In a bid to further contribute to science and increase patient safety, the company established the MotivaEdge program, a platform that provides certified education and training for healthcare professionals globally.
ESTA continues to uphold high scientific standards through its activities. In 2018, the Establishment Labs initiated the Motiva Implants® Post Approval Study in the United States, a part of its commitment to clinical science and quantitative evidence to support the safety and efficiency of its products.
Notably, ESTA works in compliance with international regulatory standards, maintaining various registrations, approvals, and certifications such as ISO 13485 and FDA registration. It continues to thrive and forge ahead, reflecting its commitment to innovation, quality, and patient safety in the field of medical technology.